Breast Cancer
FDA Approves Tykerb for Advanced Breast Cancer Patients
Published in Food and Drug Law Weekly, March 30th, 2007
The combination treatment is indicated for women who have received prior therapy with other cancer drugs, including an anthracycline, a taxane, and trastuzumab (Herceptin). According to the American Cancer Society, about 180,000 new cases of breast cancer are diagnosed each year. Approximately 8,000 to 10,000 women die from metastatic HER2 positive breast cancer each...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Food and Drug Law Weekly
More Articles from Food and Drug Law Weekly
- Asthma
Safe Drug Compounding Act of 2007 Wins Favor with Consumer Health Alliance for Safe Medication - Drug Safety
National experts and nonprofit organizations call to end FDA user fees and to improve drug safety - Fibrosis
Retired Cleveland Businessman Sues Tyco International for Rare Disease Caused by its MRI Drug, Optimark Through Law Firm of Spangenberg, Shibley & Liber - Oncology
Senior Scientist from Johnson & Johnson Testifies Before Senate HELP Committee on Follow-On Biologics - Regulatory Actions
Genta Announces Closing of Common Stock Offering - Addiction Medicine
Scientists at National Institute of Public Health describe research in addiction medicine - More from this issue of Food and Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
